Ketoconazole and Plasma and Urine Steroid Levels in Cushing's Disease (original) (raw)
1991, Clinical and Experimental Pharmacology and Physiology
Related papers
Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
Frontiers in Endocrinology
ObjectiveThe first-line treatment for Cushing’s disease is transsphenoidal surgery, after which the rates of remission are 60 to 80%, with long-term recurrence of 20 to 30%, even in those with real initial remission. Drug therapies are indicated for patients without initial remission or with surgical contraindications or recurrence, and ketoconazole is one of the main available therapies. The objective of this study was to evaluate the safety profile of and the treatment response to ketoconazole in Cushing’s disease patients followed up at the endocrinology outpatient clinic of a Brazilian university hospital.Patients and methodsThis was a retrospective cohort of Cushing’s disease patients with active hypercortisolism who used ketoconazole at any stage of follow-up. Patients who were followed up for less than 7 days, who did not adhere to treatment, or who were lost to follow-up were excluded.ResultsOf the 172 Cushing’s disease patients who were followed up between 2004 and 2020, 38...
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.